Guggenheim Maintains Buy on Bruker, Raises Price Target to $70

Benzinga Newsdesk www.benzinga.com Positive 83.1%

Neg 0% Neu 0% Pos 83.1%

Guggenheim analyst Subbu Nambi maintains Bruker (NASDAQ:BRKR) with a Buy and raises the price target from $50 to $70.

Comments

No comments yet. Be the first!